Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces boulardii for prevention of antibiotic-associated diarrhoea in hospitalized adults
2009-017374-20Phase 3Terminated
- Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Start
- Mar 2010
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of saccharomyces boulardii in antibiotic-associated diarrhea (AAD), Clostridioides difficile colitis (CDI), sponsored by Bernhard Nocht Institute for Tropical Medicine. Started Mar 2010; status: terminated.
02
Drugs
saccharomyces boulardii
03
Conditions
antibiotic-associated diarrhea (AAD)Clostridioides difficile colitis (CDI)
Beyond the preview
Go deeper on 2009-017374-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017374-20.